Drug interactions
Indacaterol inhaled + Octreotide
Severity: Moderate
Indacaterol inhaled and Octreotide: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Indacaterol, a long-acting beta2 agonist, can prolong the QT interval and cause hypokalemia and tachycardia. Octreotide may add to QT effects, so the combination could modestly raise arrhythmia risk, especially in patients with heart disease.
What this interaction means in plain words
Indacaterol inhaled and Octreotide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Why it happens
Additive QT prolongation with beta2-agonist-induced hypokalemia and sympathetic stimulation.
What to do
Monitor ECG and serum potassium in patients with cardiac risk factors. Avoid exceeding the recommended indacaterol dose.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Indacaterol inhaled and Octreotide, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Octreotide
Frequently asked questions
Can I take Indacaterol inhaled with Octreotide?
MediHelp rates the interaction as moderate. Indacaterol inhaled and Octreotide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Indacaterol, a long-acting beta2 agonist, can prolong the QT interval and cause hypokalemia and tachycardia. Octreotide may add to QT effects, so the combination could modestly raise arrhythmia risk, especially in patients with heart disease.
How serious is the interaction between Indacaterol inhaled and Octreotide?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor ECG and serum potassium in patients with cardiac risk factors. Avoid exceeding the recommended indacaterol dose.
What other medicines interact with Octreotide?
MediHelp also lists interactions of Octreotide with, for example, Adagrasib, Amisulpride, Arsenic trioxide. The full list is on the Octreotide page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
